Active Implants   Report issue

For profit
Founded: Memphis TN United States (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2014
NCT02136901
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Active Implants

Active Ingredients

Drugs in Other Trials (2)

hyaluronic acid (2 trials)

triamcinolone (kenalog) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2